Yeah, teriflunomide has been already approved in adults. So we have performed a study in children with that treatment in order to see the efficacy, the pharmacokinetics, and also the safety profile of the treatment. What the study adds is that the efficacy seems to be similar to what has been seen in adults and specifically on MRI activity, which is really significant. The safety profile seems also to be good and similar to what has been seen in adults...
Yeah, teriflunomide has been already approved in adults. So we have performed a study in children with that treatment in order to see the efficacy, the pharmacokinetics, and also the safety profile of the treatment. What the study adds is that the efficacy seems to be similar to what has been seen in adults and specifically on MRI activity, which is really significant. The safety profile seems also to be good and similar to what has been seen in adults. In children, the treatment availabilities are very low, as we can’t perform lot of studies in children. So this study has given us the opportunity to use teriflunomide in children with multiple sclerosis, actually. So these kind of studies are needed to improve the availability of these treatments in children.